| David Kern Lee, DPM | |
|
18731 N Reems Rd Ste 640, Surprise, AZ 85374-8644 | |
| (623) 328-8577 | |
| (623) 428-0363 |
| Full Name | David Kern Lee |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 33 Years |
| Location | 18731 N Reems Rd Ste 640, Surprise, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578524385 | NPI | - | NPPES |
| 119036 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 0619 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Banner Del E. Webb Medical Center | Sun city west, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Arizona Institute For Restorative Foot And Ankle Surgery Inc | 1759694573 | 2 |
News Archive
The pressure for a new product to succeed at launch has never been greater with organizations across the pharmaceutical sector facing pipeline deficits, patent expirations and increasing development costs.
MAP Pharmaceuticals, Inc. announced today it will present new analyses from the FREEDOM-301 Phase 3 clinical trial in a late breaker session at the 52nd Annual Scientific Meeting of the American Headache Society (AHS) in Los Angeles, California on Friday, June 25 from 3:30 to 4:00 pm PT. The presentation will show that the Company's investigational LEVADEX™ orally inhaled migraine therapy was effective irrespective of when it was administered during a migraine cycle.
egg health innovations (previously part of Virgo Health) has launched a new wearable technology product which provides a fully immersive, first person patient insight experience. Named "Virtual Mile" it allows someone to authentically understand another person by experiencing the world from a virtual first person vantage point, conceived from a need to capture greater insights in sensitive conditions and rare diseases.
Boston Scientific Corporation today announced comprehensive data from the TAXUS ATLAS clinical program, a series of global, prospective, single-arm trials evaluating the TAXUS Liberte Paclitaxel-Eluting Stent System in a variety of lesions and patient groups.
Systemic fungal infections are much rarer than other illnesses, but they are potentially deadly, with limited options for treatment.
› Verified 3 days ago
| Provider Name | Arizona Institute For Restorative Foot And Ankle Surgery Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1639556129 PECOS PAC ID: 1759694573 Enrollment ID: O20150722004055 |
News Archive
The pressure for a new product to succeed at launch has never been greater with organizations across the pharmaceutical sector facing pipeline deficits, patent expirations and increasing development costs.
MAP Pharmaceuticals, Inc. announced today it will present new analyses from the FREEDOM-301 Phase 3 clinical trial in a late breaker session at the 52nd Annual Scientific Meeting of the American Headache Society (AHS) in Los Angeles, California on Friday, June 25 from 3:30 to 4:00 pm PT. The presentation will show that the Company's investigational LEVADEX™ orally inhaled migraine therapy was effective irrespective of when it was administered during a migraine cycle.
egg health innovations (previously part of Virgo Health) has launched a new wearable technology product which provides a fully immersive, first person patient insight experience. Named "Virtual Mile" it allows someone to authentically understand another person by experiencing the world from a virtual first person vantage point, conceived from a need to capture greater insights in sensitive conditions and rare diseases.
Boston Scientific Corporation today announced comprehensive data from the TAXUS ATLAS clinical program, a series of global, prospective, single-arm trials evaluating the TAXUS Liberte Paclitaxel-Eluting Stent System in a variety of lesions and patient groups.
Systemic fungal infections are much rarer than other illnesses, but they are potentially deadly, with limited options for treatment.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Kern Lee, DPM 18731 N Reems Rd Ste 640, Surprise, AZ 85374-8644 Ph: (623) 328-8577 | David Kern Lee, DPM 18731 N Reems Rd Ste 640, Surprise, AZ 85374-8644 Ph: (623) 328-8577 |
News Archive
The pressure for a new product to succeed at launch has never been greater with organizations across the pharmaceutical sector facing pipeline deficits, patent expirations and increasing development costs.
MAP Pharmaceuticals, Inc. announced today it will present new analyses from the FREEDOM-301 Phase 3 clinical trial in a late breaker session at the 52nd Annual Scientific Meeting of the American Headache Society (AHS) in Los Angeles, California on Friday, June 25 from 3:30 to 4:00 pm PT. The presentation will show that the Company's investigational LEVADEX™ orally inhaled migraine therapy was effective irrespective of when it was administered during a migraine cycle.
egg health innovations (previously part of Virgo Health) has launched a new wearable technology product which provides a fully immersive, first person patient insight experience. Named "Virtual Mile" it allows someone to authentically understand another person by experiencing the world from a virtual first person vantage point, conceived from a need to capture greater insights in sensitive conditions and rare diseases.
Boston Scientific Corporation today announced comprehensive data from the TAXUS ATLAS clinical program, a series of global, prospective, single-arm trials evaluating the TAXUS Liberte Paclitaxel-Eluting Stent System in a variety of lesions and patient groups.
Systemic fungal infections are much rarer than other illnesses, but they are potentially deadly, with limited options for treatment.
› Verified 3 days ago
Heavenly Soles Pllc Podiatrist Medicare: Medicare Enrolled Practice Location: 13954 W Waddell Rd, Suite 307, Surprise, AZ 85379 Phone: 623-584-0760 Fax: 623-546-0344 | |
Dr. Marie C. Paul, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 13954 W Waddell Rd, Suite 307, Surprise, AZ 85379 Phone: 623-584-0760 Fax: 623-546-0344 | |
Foot & Ankle Specialists Of Arizona Pllc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 14973 W Bell Rd Ste 110, Surprise, AZ 85374 Phone: 623-544-9090 Fax: 623-546-3704 | |
Sanford Ralph Kaner, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 14780 W Mountain View Blvd, Suite 110, Surprise, AZ 85374 Phone: 623-374-7774 | |
Fixingfeet, Pllc Podiatrist Medicare: Medicare Enrolled Practice Location: 14823 W Bell Rd, Suite 100, Surprise, AZ 85374 Phone: 623-584-5556 Fax: 623-584-0755 | |
Travis S Jensen Dpm Pc Podiatrist Medicare: Medicare Enrolled Practice Location: 12361 W Bola Dr, Surprise, AZ 85378 Phone: 623-584-5626 | |
Dr. Viedra V Elison, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 14823 W Bell Rd, Suite 100, Surprise, AZ 85374 Phone: 623-584-5556 Fax: 623-584-0755 |